Increased right ventricular fatty acid accumulation in chronic thromboembolic pulmonary hypertension

Annals of the American Thoracic Society

Volumn 12, Issue 10, 2015, Pages 1465-1472

  Sakao, Seiichiro ^a   Miyauchi, Hideyuki ^a   Voelkel, Norbert F ^b   Sugiura, Toshihiko ^a   Tanabe, Nobuhiro ^a   Kobayashi, Yoshio ^a   Tatsumi, Koichiro ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

123I b methyl iodophenyl pentadecanoic acid; Chronic thromboembolic pulmonary hypertension; Fatty acid; Right ventricle; Thromboendarterectomy

Indexed keywords

FATTY ACID; IODOFILTIC ACID I 123; 2-IODOPHENOL; IODOBENZENE; PENTADECANOIC ACID;

ADULT; AGED; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CT-SPECT SCANNER; DIASTOLIC BLOOD PRESSURE; ENDARTERECTOMY; EXERCISE TOLERANCE; FATTY ACID METABOLISM; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HEART VENTRICLE WALL; HUMAN; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PULMONARY THROMBOENDARTERECTOMY; SYSTOLIC BLOOD PRESSURE; CASE CONTROL STUDY; ECHOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; HEMODYNAMICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY EMBOLISM; PULMONARY HYPERTENSION; SCINTISCANNING;

AGED; CARDIAC CATHETERIZATION; CASE-CONTROL STUDIES; ENDARTERECTOMY; FATTY ACIDS; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; IODOBENZENES; MALE; MIDDLE AGED; PULMONARY EMBOLISM; VENTRICULAR FUNCTION, RIGHT;

EID: 84943641390     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201504-236LE     Document Type: Article

References (27)

1. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951-1960.
2. van Wolferen SA, Marcus JT, Westerhof N, Spreeuwenberg MD, Marques KM, Bronzwaer JG, Henkens IR, Gan CT, Boonstra A, Postmus PE, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008;29:120-127.
3. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol 1998;275:H1948-H1956.
4. Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, et al. Increased [18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005;45:1849-1855.
5. Handa N, Magata Y, Mukai T, Nishina T, Konishi J, Komeda M. Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo. Ann Nucl Med 2007;21:569-576.
6. Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) 2010;88:47-60.
7. Marsboom G, Wietholt C, Haney CR, Toth PT, Ryan JJ, Morrow E, Thenappan T, Bache-Wiig P, Piao L, Paul J, et al. Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 2012;185:670-679.
8. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions. Cardiovasc Res 1997;33:243-257.
9. Fang YH, Piao L, Hong Z, Toth PT, Marsboom G, Bache-Wiig P, Rehman J, Archer SL. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randles cycle. J Mol Med (Berl) 2012;90:31-43.
10. Buermans HP, Redout EM, Schiel AE, Musters RJ, Zuidwijk M, Eijk PP, van Hardeveld C, Kasanmoentalib S, Visser FC, Ylstra B, et al. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics 2005;21:314-323.
11. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Dekkers DH, Duncker DJ, Helbing WA, Lamers JM. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 2005;5:2519-2530.
12. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoeven AJ, Duncker DJ, Helbing WA, Lamers JM. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Mol Cell Cardiol 2007;43:197-209.
13. Kim Y, Goto H, Kobayashi K, Sawada Y, Miyake Y, Fujiwara G, Chiba H, Okada T, Nishimura T. Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessment by I-123 b-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography. Ann Nucl Med 1997;11:207-212.
14. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
15. De Geeter F, Franken PR, Knapp FF Jr, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyliodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
16. Sato H, Iwasaki T, Toyama T, Kaneko Y, Inoue T, Endo K, Nagai R. Prediction of functional recovery after revascularization in coronary artery disease using (18)F-FDG and (123)I-BMIPP SPECT. Chest 2000;117:65-72.
17. Biswas SK, Sarai M, Hishida H, Ozaki Y. 123I-BMIPP fatty acid analogue imaging is a novel diagnostic and prognostic approach following acute myocardial infarction. Singapore Med J 2009;50:943-948.
18. Sakao S, Miyauchi H, Jujo T, Sugiura T, Shigeta A, Tanabe N, Kobayashi Y, Tatsumi K. Increased right ventricular 123I-BMIPP fatty acid accumulation in patients with chronic thromboembolic pulmonary hypertension [abstract]. Am J Respir Crit Care Med 2015;191:A5141.
19. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013;62:D92-D99.
20. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 2004;109:1580-1589.
21. Gomez-Arroyo J, Mizuno S, Szczepanek K, Van Tassell B, Natarajan R, dos Remedios CG, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, et al. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail 2013;6:136-144.
22. Kiriyama T, Kumita S, Moroi M, Nishimura T, Tamaki N, Hasebe N, Kikuchi K. Interpretative variability and its impact on the prognostic value of myocardial fatty acid imaging in asymptomatic hemodialysis patients in a multicenter trial in Japan. Circ J 2015;79:153-160.
23. Abe H, Iguchi N, Utanohara Y, Inoue K, Takamisawa I, Seki A, Tanizaki K, Takeda N, Tohbaru T, Asano R, et al. Non-invasive diagnosis of coronary artery disease by 123I-BMIPP/201TlCl dual myocardial SPECT in patients with heart failure. Int J Cardiol 2014;176:969-974.
24. Ko T, Utanohara Y, Suzuki Y, Kurihara M, Iguchi N, Umemura J, Sumiyoshi T, Tomoike H. A preliminary feasibility study of simultaneous dual-isotope imaging with a solid-state dedicated cardiac camera for evaluating myocardial perfusion and fatty acid metabolism. Heart Vessels [online ahead of print] 13 Sept 2014; DOI: 10.1007/s00380-014-0578-4.
25. Hagberg C, Mehlem A, Falkevall A, Muhl L, Eriksson U. Endothelial fatty acid transport: role of vascular endothelial growth factor B. Physiology (Bethesda) 2013;28:125-134.
26. Serpi R, Tolonen AM, Huusko J, Rysä J, Tenhunen O, Ylä-Herttuala S, Ruskoaho H. Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats. Cardiovasc Res 2011;89:204-213.
27. Al-Husseini A, Kraskauskas D, Mezzaroma E, Nordio A, Farkas D, Drake JI, Abbate A, Felty Q, Voelkel NF. Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension. Pulm Circ 2015;5:101-116.